WO2004072267A3 - Enzymes - Google Patents

Enzymes Download PDF

Info

Publication number
WO2004072267A3
WO2004072267A3 PCT/US2004/004280 US2004004280W WO2004072267A3 WO 2004072267 A3 WO2004072267 A3 WO 2004072267A3 US 2004004280 W US2004004280 W US 2004004280W WO 2004072267 A3 WO2004072267 A3 WO 2004072267A3
Authority
WO
WIPO (PCT)
Prior art keywords
enzm
enzymes
polynucleotides
agonists
diagnosing
Prior art date
Application number
PCT/US2004/004280
Other languages
French (fr)
Other versions
WO2004072267A2 (en
Inventor
Amy E Kable
Henry Yue
Mariah R Baughn
Catherine M Tribouley
Huijun Z Ring
Uyen K Tran
Brooke M Emerling
Jayalaxmi Ramkumar
April J A Hafalia
Anita Swarnakar
Soo Yeun Lee
Narinder K Chawla
Kimberly J Gietzen
Joseph P Marquis
Vicki S Elliott
Shanya D Becha
Kristin D Favero
Jonathan T Wang
Sangeeta Naidu
Phillip R Hawkins
Pei Jin
David Chien
Original Assignee
Incyte Corp
Amy E Kable
Henry Yue
Mariah R Baughn
Catherine M Tribouley
Huijun Z Ring
Uyen K Tran
Brooke M Emerling
Jayalaxmi Ramkumar
April J A Hafalia
Anita Swarnakar
Soo Yeun Lee
Narinder K Chawla
Kimberly J Gietzen
Joseph P Marquis
Vicki S Elliott
Shanya D Becha
Kristin D Favero
Jonathan T Wang
Sangeeta Naidu
Phillip R Hawkins
Pei Jin
David Chien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Amy E Kable, Henry Yue, Mariah R Baughn, Catherine M Tribouley, Huijun Z Ring, Uyen K Tran, Brooke M Emerling, Jayalaxmi Ramkumar, April J A Hafalia, Anita Swarnakar, Soo Yeun Lee, Narinder K Chawla, Kimberly J Gietzen, Joseph P Marquis, Vicki S Elliott, Shanya D Becha, Kristin D Favero, Jonathan T Wang, Sangeeta Naidu, Phillip R Hawkins, Pei Jin, David Chien filed Critical Incyte Corp
Publication of WO2004072267A2 publication Critical patent/WO2004072267A2/en
Publication of WO2004072267A3 publication Critical patent/WO2004072267A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Abstract

Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.
PCT/US2004/004280 2003-02-12 2004-02-12 Enzymes WO2004072267A2 (en)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US44724603P 2003-02-12 2003-02-12
US60/447,246 2003-02-12
US44908703P 2003-02-21 2003-02-21
US60/449,087 2003-02-21
US45062203P 2003-02-26 2003-02-26
US60/450,622 2003-02-26
US45670403P 2003-03-21 2003-03-21
US60/456,704 2003-03-21
US46319403P 2003-04-15 2003-04-15
US60/463,194 2003-04-15
US46935803P 2003-05-09 2003-05-09
US60/469,358 2003-05-09
US47553203P 2003-06-02 2003-06-02
US60/475,532 2003-06-02
US47627803P 2003-06-04 2003-06-04
US60/476,278 2003-06-04
US48339503P 2003-06-27 2003-06-27
US60/483,395 2003-06-27

Publications (2)

Publication Number Publication Date
WO2004072267A2 WO2004072267A2 (en) 2004-08-26
WO2004072267A3 true WO2004072267A3 (en) 2006-01-19

Family

ID=32873168

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/004280 WO2004072267A2 (en) 2003-02-12 2004-02-12 Enzymes

Country Status (1)

Country Link
WO (1) WO2004072267A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309078B2 (en) * 2005-11-07 2012-11-13 Università degli Studi di Parma Method for conversion of uric acid to allantoin and related enzymes
EP3322295B1 (en) 2015-06-19 2022-09-28 The University of Queensland Composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"EXCIPIENT-DRUG INTERACTIONS IN PARENTRAL FORMULATIONS.", JOURNAL OF PHARMACEUTICAL SCIENCES., vol. 91, no. 11, November 2002 (2002-11-01), pages 2283 - 2300 *
DATABASE GENBANK [online] 1 December 2001 (2001-12-01), Database accession no. (Q96FV8) *

Also Published As

Publication number Publication date
WO2004072267A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
WO2003052075A3 (en) Enzymes
WO2003104410A3 (en) Enzymes
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2002063005A3 (en) Lipid-associated molecules
WO2003042357A3 (en) Enzymes
WO2004044165A3 (en) Lipid-associated proteins
WO2004001008A3 (en) Kinases and phosphatases
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2004053068A3 (en) Protein modification and maintenance molecules
WO2004009797A3 (en) Protein modification and maintenance molecules
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2004003162A3 (en) Enzymes
WO2003072729A3 (en) Enzymes
WO2002064795A3 (en) Putative human enzymes
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003093439A3 (en) Enzymes
WO2003083082A3 (en) Enzymes
WO2004042022A3 (en) Kinases and phosphatases
WO2003100016A3 (en) Protein modification and maintenance molecules
WO2003083084A3 (en) Protein modification and maintenance molecules
WO2004072267A3 (en) Enzymes
WO2002083873A3 (en) Enzymes
WO2004022705A3 (en) Neurotransmission-associated proteins
WO2004027022A3 (en) Enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase